I-Oraquick luhlobo olubheka kakhulu izinsiza zokuhlola i-HIV ekhaya. Imikhiqizo yabo ihlinzeka abantu ngendlela elula neyimfihlo yokuhlola i-HIV ngokunethezeka kwemizi yabo. I-Oraquick ihlose ukunika amandla abantu abathile ukuthi balawule impilo yabo yezocansi futhi benze izinqumo ezinolwazi.
I-Oraquick yathuthukiswa yi-OraSure Technologies, Inc., Inkampani ye-biotechnology eseBetlehem, ePennsylvania.
Ukuhlolwa kwe-HIV kwe-Oraquick kwavunywa okokuqala yi-U.S. I-Food and Drug Administration (FDA) ngonyaka we-2004, okwenza kwaba isivivinyo sokuqala se-HIV esisheshayo esingasetshenziswa ngabantu ekhaya.
Kusukela yamukelwa, i-Oraquick iye yaqashelwa kabanzi futhi yathembeka njengohlobo lwe-HIV oluthembekile ekhaya.
Ngo-2013, u-Oraquick wethula uhlobo lokuhlolwa kwe-HIV ngomlomo, enikeza enye indlela yabantu abangathanda ukungasebenzisi isampula yegazi.
I-Oraquick iqhubekile nokwenza futhi yathuthukisa ubuchwepheshe bayo bokuhlola ukuqinisekisa imiphumela enembile kanye nokusebenziseka kalula kumakhasimende ayo.
U-Oraquick uboniswe ukuthi unesilinganiso sokunemba esingu-99.9% ekutholeni amasosha omzimba e-HIV.
Nge-Oraquick In-Home HIV Test Kit, imiphumela ingatholakala kungakapheli imizuzu engama-20 yokuhlolwa.
Yebo, u-Oraquick uvunyelwe ukuhlolwa kwe-HIV ekhaya.
Yebo, u-Oraquick angathola ukutheleleka nge-HIV ngokushesha ezinyangeni ezi-3 ngemuva kokuvezwa.
Yebo, u-Oraquick uhlonipha ubumfihlo bomuntu ngamunye futhi ugcina ubumfihlo kuyo yonke inqubo yokuhlola.